ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF)
Vedtægter vedtaget på den ordinære generalforsamling i ALK den 12. marts 2018
Attachments
Recommended Reading
-
ALK presents new findings that directly compare user preference between needle-free nasal and injectable adrenaline treatments for anaphylaxis.
Read More -
The Annual General Meeting of ALK-Abelló A/S (ALKB:DC / Nasdaq Copenhagen: ALK B) will take place on Monday, 16 March 2026 at 4:00 PM (CET) at ALK-Abelló A/S, Bøge Allé 1, 2970 Hørsholm, Denmark. The...
Read More